Skip Navigation
Return to All Schools

The Saul and Doris Farber Professorship in Clinical Care and Investigation in Pediatric Oncology

School of Medicine

Established in 2017 by Joshua Farber, MD in honor of Saul & Doris Farber

JOSHUA FARBER, MD, and his wife NANCY HARDY, MD, along with their friends and family, established the Saul and Doris Farber Professorship to honor the legacy of Josh’s parents, Saul and Doris, and to recognize the efforts of the faculty who worked to help their son Daniel win his battle with leukemia. The professorship expresses their profound thanks for those whose had cared for their son, and whose dedication and perseverance had rendered his disease curable.

Josh’s father, Saul, was also a physician and held many leadership posts in American medicine, though perhaps his greatest impact was as an educator and role model for generations of physicians at NYU and Bellevue Hospital. His wife, Doris Farber, JD, owned and operated the family’s retail furniture store. After retiring from the family business, Mrs. Farber helped in managing the social aspects of Dr. Farber’s career, and was an avid participant in New York’s civic and cultural life.

In recognition of the impact Saul and Doris had on their family and their community, Josh believes it is a fitting tribute to provide an endowment in his parents’ names, contributing to the ongoing efforts to cure childhood cancers while also recognizing the work of a physician-scientist who meant so much to his family.

Held by Allen Chen

Dr. ALLEN CHEN obtained his MD and PhD in tumor immunology from Duke University in 1986 and moved to Seattle for pediatric residency and hematology/oncology fellowship at the University of Washington affiliated hospitals and Fred Hutchinson Cancer Research Center. Dr. Chen was recruited to Johns Hopkins to lead the pediatric bone marrow transplantation (BMT) program. Here, he completed his MHS in clinical investigation at the Bloomberg School of Public Health to develop clinical translational research skills, and in the process was grounded in the science of safety.

His clinical focus is in bone marrow transplantation, with the fascinating interplay of chemoradiotherapy that can exceed a lethal marrow dose; donor and recipient immune systems that may reject each other or cooperate to protect the recipient and provide an anti-tumor effect; and stem cells that can last a lifetime and differentiate into a full spectrum of cell types. He has led clinical trials both to induce the patient’s own cryopreserved marrow to attack tumor cells and to prevent donor marrow grafts from attacking patient tissues.

Because he cares for this most complex and vulnerable patient population, Chen is deeply aware of the need to develop better systems to deliver safe care. Before medical school, he worked as a programmer-analyst in the Laboratory of Computer Science at Massachusetts General Hospital, and he has been involved in the selection and deployment of clinical systems since joining the faculty at Johns Hopkins. He demonstrated a 40% reduction in reported medication-related events with deployment of computerized order entry in pediatric oncology. He continues to study issues ranging from patient identification to medication reconciliation, to improve the safe delivery of care throughout the Johns Hopkins Health System and beyond.